J.P. Morgan Private Wealth Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $266K | Hold |
4,515
| – | – | ﹤0.01% | 1529 |
|
2023
Q2 | $270K | Sell |
4,515
-612
| -12% | -$36.5K | ﹤0.01% | 1280 |
|
2023
Q1 | $300K | Sell |
5,127
-192
| -4% | -$11.2K | ﹤0.01% | 1679 |
|
2022
Q4 | $330K | Sell |
5,319
-33
| -0.6% | -$2.05K | ﹤0.01% | 1623 |
|
2022
Q3 | $303K | Hold |
5,352
| – | – | ﹤0.01% | 1642 |
|
2022
Q2 | $342K | Buy |
5,352
+3
| +0.1% | +$192 | ﹤0.01% | 1598 |
|
2022
Q1 | $346K | Sell |
5,349
-7,584
| -59% | -$491K | ﹤0.01% | 1693 |
|
2021
Q4 | $861K | Buy |
12,933
+5,622
| +77% | +$374K | ﹤0.01% | 1321 |
|
2021
Q3 | $446K | Buy |
7,311
+3
| +0% | +$183 | ﹤0.01% | 1541 |
|
2021
Q2 | $453K | Buy |
7,308
+1,110
| +18% | +$68.8K | ﹤0.01% | 1515 |
|
2021
Q1 | $367K | Sell |
6,198
-2,097
| -25% | -$124K | ﹤0.01% | 1443 |
|
2020
Q4 | $496K | Buy |
8,295
+1,287
| +18% | +$77K | ﹤0.01% | 1293 |
|
2020
Q3 | $382K | Sell |
7,008
-2,145
| -23% | -$117K | ﹤0.01% | 1261 |
|
2020
Q2 | $470K | Buy |
9,153
+153
| +2% | +$7.86K | ﹤0.01% | 1134 |
|
2020
Q1 | $404K | Buy |
9,000
+12
| +0.1% | +$539 | ﹤0.01% | 1011 |
|
2019
Q4 | $480K | Sell |
8,988
-243
| -3% | -$13K | ﹤0.01% | 1067 |
|
2019
Q3 | $430K | Sell |
9,231
-105
| -1% | -$4.89K | ﹤0.01% | 1050 |
|
2019
Q2 | $469K | Sell |
9,336
-105
| -1% | -$5.28K | ﹤0.01% | 1013 |
|
2019
Q1 | $485K | Sell |
9,441
-966
| -9% | -$49.6K | ﹤0.01% | 1050 |
|
2018
Q4 | $488K | Buy |
10,407
+135
| +1% | +$6.33K | ﹤0.01% | 980 |
|
2018
Q3 | $575K | Buy |
10,272
+3
| +0% | +$168 | ﹤0.01% | 1020 |
|
2018
Q2 | $518K | Buy |
10,269
+300
| +3% | +$15.1K | ﹤0.01% | 998 |
|
2018
Q1 | $490K | Hold |
9,969
| – | – | ﹤0.01% | 879 |
|
2017
Q4 | $513K | Buy |
9,969
+111
| +1% | +$5.71K | ﹤0.01% | 861 |
|
2017
Q3 | $514K | Buy |
9,858
+3,915
| +66% | +$204K | ﹤0.01% | 831 |
|
2017
Q2 | $307K | Hold |
5,943
| – | – | ﹤0.01% | 1009 |
|
2017
Q1 | $299K | Buy |
+5,943
| New | +$299K | ﹤0.01% | 1068 |
|
2016
Q4 | – | Sell |
-8,241
| Closed | -$411K | – | 1271 |
|
2016
Q3 | $411K | Buy |
8,241
+357
| +5% | +$17.8K | ﹤0.01% | 859 |
|
2016
Q2 | $380K | Sell |
7,884
-102
| -1% | -$4.92K | ﹤0.01% | 883 |
|
2016
Q1 | $365K | Sell |
7,986
-375
| -4% | -$17.1K | ﹤0.01% | 871 |
|
2015
Q4 | $451K | Buy |
8,361
+147
| +2% | +$7.93K | ﹤0.01% | 728 |
|
2015
Q3 | $405K | Buy |
8,214
+2,325
| +39% | +$115K | 0.01% | 691 |
|
2015
Q2 | $343K | Buy |
5,889
+900
| +18% | +$52.4K | ﹤0.01% | 798 |
|
2015
Q1 | $286K | Sell |
4,989
-573
| -10% | -$32.8K | ﹤0.01% | 907 |
|
2014
Q4 | $281K | Sell |
5,562
-225
| -4% | -$11.4K | ﹤0.01% | 896 |
|
2014
Q3 | $271K | Buy |
5,787
+717
| +14% | +$33.6K | ﹤0.01% | 876 |
|
2014
Q2 | $228K | Buy |
+5,070
| New | +$228K | ﹤0.01% | 778 |
|